ImClone Systems

John H. Johnson, formerly of Johnson & Johnson, has been named chief executive officer, ImClone Systems, effective August 27th. Mr. Johnson has more than two decades of executive and operational management experience in the biopharmaceutical and healthcare industries. He has held senior management positions of increasing responsibility at J&J and most recently served as company group chairman of its worldwide biopharmaceuticals unit, where he was responsible for the biotechnology, immunology and oncology commercial businesses, including Centocor, Ortho Biotech Products and the Worldwide Strategic Marketing Group.

“John has a strong track record in the biopharmaceutical industry and we are happy to have him serving as chief executive officer during this new era for ImClone,” said Alexander J. Denner, Ph.D., chairman of the executive committee of ImClone Systems.